ZNF136 Inhibitors
Zinc Finger Protein 136 (ZNF136) is a transcription factor belonging to the Krüppel C2H2-type zinc-finger protein family, which is characterized by its finger-like protrusions that bind to specific DNA sequences, acting as pivotal molecular switches in the regulation of gene expression. The precise biological roles of ZNF136 are not fully elucidated, but it is known to be involved in the intricate web of genetic transcription. The expression of ZNF136 is a finely-tuned process, pivotal for the normal functioning of various cellular processes. It is understood that ZNF136, by virtue of its position as a transcription factor, could have a broad impact on numerous cellular pathways. The protein's interaction with DNA allows it to control the transcriptional fate of genes, making it a noteworthy point of study in the field of gene regulation. With ongoing research, the understanding of ZNF136's role in the transcriptional landscape continues to expand, uncovering new facets of its function and interaction with other cellular constituents.
In the realm of molecular biology, the modulation of gene expression is a fundamental area of study, and the inhibition of specific transcription factors such as ZNF136 presents a complex challenge. Chemical compounds that influence the expression of transcription factors operate through various mechanisms. For instance, DNA methyltransferase inhibitors like 5-Azacytidine and Decitabine may induce demethylation at promoter regions of genes, potentially reducing the expression levels of ZNF136 by altering the transcriptional control. Histone deacetylase (HDAC) inhibitors, including Trichostatin A and Vorinostat, can facilitate a more open chromatin state, which may suppress the transcriptional activity of ZNF136 by changing how accessible the DNA is to the transcriptional machinery. Compounds such as Chloroquine, which intercalate into DNA, are known to obstruct the transcriptional machinery itself, potentially leading to a decrease in ZNF136 transcription. The action of these compounds is not solely specific to ZNF136, as they target broader pathways of gene expression and chromatin modification. Their potential to downregulate ZNF136 expression is based on the understanding that altering the epigenetic and transcriptional landscape can lead to downstream effects on the expression of this transcription factor, amongst others. Nonetheless, the direct link between these compounds and the inhibition of ZNF136 expression remains a topic for rigorous scientific inquiry.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This agent could induce hypomethylation of DNA at sites critical for ZNF136 transcription, leading to its decreased expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
By inhibiting histone deacetylase, Trichostatin A may cause chromatin decondensation around ZNF136 target loci, potentially resulting in downregulation of ZNF136. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
This compound may bind to DNA sequences that are essential for ZNF136 transcription, thereby inhibiting its expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Its binding to GC-rich DNA sequences could prevent the transcription of ZNF136 by blocking promoter access. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG 108 may impede DNA methyltransferases, which could lead to a reduction in ZNF136 expression through promoter demethylation. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
By inhibiting DNA methylation, 5-Aza-2′-Deoxycytidine may lead to the reactivation of silenced genes, potentially reducing ZNF136 expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine's DNA intercalating property might obstruct the transcriptional machinery necessary for ZNF136 transcription, leading to its reduced expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
Sodium Butyrate, as an HDAC inhibitor, may result in hyperacetylation of histones, which could lead to the decreased expression of ZNF136 by altering chromatin accessibility. | ||||||
Oxamflatin | 151720-43-3 | sc-205960 sc-205960A | 1 mg 5 mg | $148.00 $461.00 | 4 | |
This HDAC inhibitor may lead to enhanced histone acetylation, thereby repressing the expression of ZNF136 by altering chromatin structure. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid may induce hyperacetylation of histones at ZNF136 promoter regions, resulting in the repression of ZNF136 expression. | ||||||